Page last updated: 2024-10-27

gabexate and Anasarca

gabexate has been researched along with Anasarca in 6 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"The present study investigated the protective effects of the new potent synthetic protease inhibitors, ONO3307 (4-sulfamoyl phenyl-4-guanidinobenzoate methanesulfonate) and FOY007 (gabexate misilate), on the exocrine pancreas in rat caerulein-induced acute pancreatitis in both in vitro and in vivo experiments."3.68Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007. ( Hirano, T; Manabe, T; Tobe, T, 1992)
"The current study was done to evaluate the subacute toxic effects of cyclosporin A (CS) on the exocrine pancreas and the protective effect of potent protease inhibitor camostate (FOY-305)."1.28Cytotoxic effects of cyclosporin A on the exocrine pancreas in rats. ( Hirano, T; Manabe, T; Printz, H; Tobe, T, 1992)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, H1
Song, Q1
Lv, F1
Wang, S1
Wang, Y1
Li, X1
Luo, Y1
Mei, X1
Tang, J1
Hoffmeister, C1
Trevisan, G1
Rossato, MF1
de Oliveira, SM1
Gomez, MV1
Ferreira, J1
Hirano, T2
Manabe, T2
Printz, H1
Tobe, T2
Bassi, C1
Benetti, L1
Girelli, R1
Falconi, M1
Nifosí, F1
Coviello, G1
Cavallini, G1
Vesentini, S1
Dragonetti, C1
Pederzoli, P1
Yamasaki, Y1
Kuroshima, T1
Tsuji, K1
Kawamoto, H1
Higashimoto, Y1

Other Studies

6 other studies available for gabexate and Anasarca

ArticleYear
Protection Provided by a Gabexate Mesylate Thermo-Sensitive
    Gut and liver, 2017, Jan-15, Volume: 11, Issue:1

    Topics: Abdominal Injuries; Amylases; Animals; Apoptosis; Ascites; C-Reactive Protein; Edema; Gabexate; Gels

2017
Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats.
    Pain, 2011, Volume: 152, Issue:8

    Topics: Acrylamides; Anilides; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Antioxidants; Bridged B

2011
Cytotoxic effects of cyclosporin A on the exocrine pancreas in rats.
    Surgery, gynecology & obstetrics, 1992, Volume: 175, Issue:6

    Topics: Amylases; Animals; Cathepsin B; Cyclosporine; Drug Evaluation, Preclinical; Edema; Esters; Gabexate;

1992
Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
    Pharmacology, 1992, Volume: 45, Issue:2

    Topics: Acute Disease; Amylases; Animals; Body Water; Cathepsin B; Ceruletide; Edema; Gabexate; Guanidines;

1992
Early graft injuries after pancreatic transplantation in syngeneic rats. Cytoprotective effects of gabexate-mesilate.
    International journal of pancreatology : official journal of the International Association of Pancreatology, 1991, Volume: 8, Issue:4

    Topics: Analysis of Variance; Animals; Edema; Gabexate; Graft Survival; Necrosis; Organ Preservation; Pancre

1991
[Protective effect of camostat mesilate and allopurinol in acute edematous pancreatitis in the rat induced by excessive doses of caerulein].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1987, Volume: 84, Issue:7

    Topics: Acute Disease; Allopurinol; Animals; Ceruletide; Edema; Esters; Gabexate; Guanidines; Male; Pancreat

1987